Reported Earlier: Bruker Announces New Orders For Advanced Nuclear Magnetic Resonance Instrumentation From NYSBC, University Of Delaware And Northwestern University; Value Of These Three Federally Funded NMR Orders Is ~$10M, And They Are Expected To Be Delivered And Installed Next Year In 2026

Bruker Corporation (NASDAQ:BRKR) today announced new orders for advanced Nuclear Magnetic Resonance (NMR) instrumentation from the New York Structural Biology Center (NYSBC), the University of Delaware and Northwestern University. Supported by the National Institutes of Health (NIH) and the National Science Foundation (NSF), these high-performance systems will enable leading research teams to pursue breakthroughs across a wide range of scientific research, drug discovery and disease biology disciplines.

NMR Relaxometry system featuring a Field Cycling Coil (FCC, in purple) and a Fast Shuttle System mounted atop the superconducting magnet, for rapid sample transfer between the magnet and the FCC

The New York Structural Biology Center (NYSBC) ordered an NIH-funded Multifield NMR Relaxometry System. This advanced relaxometry system will be the first in North America and serves a consortium of nine research institutions in New York State as well as the national community through the NIH-funded Center on Macromolecular Dynamics by NMR spectroscopy. The system consists of a fast NMR sample shuttle system, a magnetic tunnel, and an electromagnetic field cycling coil (FCC), all mounted on a 700 MHz superconducting NMR magnet.

The aggregate value of these three federally funded NMR orders is approximately $10 million, and they are expected to be delivered and installed next year in 2026.